Development of fibrin derivatives for controlled release of heparin- binding growth factors

Journal of Controlled Release

Volumn 65, Issue 3, 2000, Pages 389-402

  Sakiyama Elbert, Shelly E ^a,b   Hubbell, Jeffrey A ^a  

^a ETH ZURICH   (Switzerland)

^b California Institute of Technology   (United States)

Author keywords

Basic fibroblast growth factor; Factor XIIIa; Fibrin; Heparin; Nerve regeneration

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; FIBRIN; FIBROBLAST GROWTH FACTOR;

ARTICLE; CHICKEN; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; MATHEMATICAL MODEL; NERVE REGENERATION; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; WOUND HEALING;

ALGORITHMS; ANIMALS; ANTICOAGULANTS; ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; CELLS, CULTURED; CHICK EMBRYO; COAGULANTS; CROSS-LINKING REAGENTS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; EXCIPIENTS; FIBRIN; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; HEPARIN; KINETICS; MODELS, THEORETICAL; NEURONS; PROTEIN BINDING; TRANSGLUTAMINASES;

EID: 0033997601     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(99)00221-7     Document Type: Article

References (40)

1. Gailit J., Clarke C., Newman D., Tonnesen M., Mosesson M., Clark R. Human fibroblasts bind directly to fibrinogen at RGD sites through integrin alpha(v)beta3. Exp. Cell Res. 232:(1):1997;118-126.
2. Horch R., Bannasch H., Kopp J., Andree C., Stark G. Single-cell suspensions of cultured human keratinocytes in fibrin-glue reconstitute the epidermis. Cell Transplant. 7:(3):1998;309-317.
3. Meana A., Iglesias J., Del Rio M., et al. Large surface of cultured human epithelium obtained on a dermal matrix based on live fibroblast-containing fibrin gels. Burns. 24:(7):1998;621-630.
4. Romanos G., Strub J. Effect of Tissucol on connective tissue matrix during wound healing: an immunohistochemical study in rat skin. J. Biomed. Mater. Res. 39:(3):1998;462-468.
5. Hunziker E., Rosenberg L. Repair of partial-thickness defect in articular cartilage: cell recruitment from the synovial membrane. J. Bone Joint Surg. Am. 78:(5):1996;721-733.
6. Williams L., Varon S. Modification of fibrin matrix formation in situ enhances nerve regeneration in silicone chambers. J. Comp. Neurol. 231:1985;209-220.
7. Isogai N., Kamiishi H., Chichibu S. Re-endothelialization stages at the microvascular anastomosis. Microsurgery. 9:(2):1988;87-94.
8. Pittman R., Ivins J., Buettner H. Neuronal plasminogen activators: cell surface binding sites and involvement in neurite outgrowth. J. Neurosci. 9:(12):1989;4269-4286.
9. Krystosek A., Seeds N. Peripheral neurons and Schwann cells secret plasminogen activator. J. Cell Biol. 98:(2):1984;773-776.
10. Herbert C., Bittner G., Hubbell J. Effect of fibrinolysis on neurite growth from dorsal root ganglia cultured in two- and three-dimensionsal fibrin gels. J. Comp. Neurol. 365:(3):1996;380-391.
11. Roghani M., Mansukhani A., Dell'Era P., Bellosta P., Basilico C., Rifkin D., Moscatelli D. Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. J. Biol. Chem. 269:(6):1994;3976-3984.
12. Rifkin D., Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109:(1):1989;1-6.
13. Vlodavsky I., Fuks Z., Ishai-Nichaeli R., Bashkin P., Levi E., Korner G.B.-S., Klagsbrun R.M. Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis. J. Cell. Biochem. 45:(2):1991;167-176.
14. Baird A., Walicke P. Fibroblast growth factors. Br. Med. Bull. 45:(2):1989;438-452.
15. Cordeiro P., Seckel B., Lipton S., D'Amore P., Wagner J., Madison R. Acidic fibroblast growth factor enhances peripheral nerve regeneration in-vivo. Plast. Reconstr. Surg. 83:(6):1989;1013-1021.
16. Otto D., Unsicker K., Grothe C. Pharmacological effects of nerve growth factor and fibroblast growth factor applied to the transectioned sciatic nerve on cell death in adult rat DRG. Neurosci. Lett. 83:(1-2):1987;156-160.
17. Danielsen N., Peltman B., Vahlsing H., Manthorpe M., Varon S. Fibroblast growth factor effects on peripheral nerve regeneration in a silicone chamber model. J. Neurosci. Res. 20:(3):1988;320-330.
18. Aebischer P., Salessiotis A.N., Winn S.R. Basic fibroblast growth factor released from synthetic guidance channels facilitates peripheral nerve regeneration across long nerve gaps. J. Neurosci. Res. 23:(3):1989;232-289.
19. Edelman E., Nugent M., Smith L., Karnovsky M. Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. J. Clin. Invest. 89:(2):1992;465-473.
20. Schense J., Hubbell J. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. Bioconjug. Chem. 10:(1):1999;75-81.
21. S. Sakiyama, J. Schense, J. Hubbell, Heparin-binding peptides enhance neurite extension in three-dimensional fibrin gels, FASEB J. 13 (15) (1999) in press.
22. Presta M., Maier J., Rusnati M., Ragniotti G. Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form. J. Cell. Physiol. 140:(1):1989;68-74.
23. Madsen N., Sincovec R. ALGORITHM 540 PDECOL, general collocation software for partial differential equations. ACM TOMS. 5:(3):1979;326-351.
24. Hopkins T. Remark on Algorithm 540. ACM TOMS. 18:(3):1992;343-344.
25. Ichinose A., Tamaki T., Aoki N. Factor XIII-mediated cross-linking of NH2-terminal peptide of α2-plasmin inhibitor to fibrin. FEBS Lett. 152:(2):1983;369-371.
26. Tyler-Cross R., Sobel M., Marques D., Harris R. Heparin binding domain peptides of antithrombin III: analysis by isothermal titration calorimetry and circular dichroism spectroscopy. Protein Sci. 3:(4):1994;620-627.
27. Fields G., Noble R. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int. J. Pept. Protein Res. 35:(3):1990;161-214.
28. Varon S. The isolation and assay of the NGF proteins. Freid R. Methods in Neurochemistry. 1972;203-209 Marcel Dekker, New York.
29. Wang J., Aspenberg P. Basic fibroblast growth factor enhances bone-graft incorporation: dose and time dependence in rats. J. Orthop. Res. 14:(2):1996;316-323.
30. L'Heureux N., Paquet S., Labbe R., Germain L., Auger F. A completely biological tissue-engineered human blood vessel. FASEB J. 12:(1):1998;47-56.
31. Black A., Berthod F., L'heureux N., Germain L., Auger F. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. FASEB J. 12:(13):1998;1331-1340.
32. Mooney D., Sano K., Kaufmann P., Majahod K., Scholoo B., Vacant J., Langer R. Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J. Biomed. Mater. Res. 37:(3):1997;413-420.
33. Sims C., Butler P., Cao Y., Casanova R., Randolph M., Black A., Vacanti C., Yaremchuk M. Tissue engineered neocartilage using plasma derived polymer substrates and chondrocytes. Plast. Reconstr. Surg. 101:(6):1998;1580-1585.
34. Schroeder-Tefft J., Bentz H., Estridge T. Collagen and heparin matrices for growth factor delivery. J. Control. Release. 49:(2-3):1997;291-298.
35. Nugent M., Edelman E. Kinetics of bFGF binding to its receptor and heparin sulfate proteoglycan: a mechanism for cooperativity. Biochemistry. 31:(37):1992;8876-8883.
36. Tyler-Cross R., Sobel M., McAdory L., Harris R. Structure-function relations of antithrombin III-heparin interactions as assessed by biophysical and biological assays and molecular modeling of peptide-pentasaccharide-docked complexes. Arch. Biochem. Biophys. 334:(2):1996;206-213.
37. Kridlel S., Chan W., Knauer D. Requirement of lysine residues outside of the proposed pentasaccharide binding region for high affinity heparin binding and activation of human antithrombin III. J. Biol. Chem. 271:(34):1996;20935-20941.
38. Olson S., Srinivasan D., Bjork I., Shore J. Binding of high affinity heparin to antithrombin III. Stopped flow kinetic studies of the binding interaction. J. Biol. Chem. 256:(21):1981;11073-11079.
39. Saltzman W., Radomxky M., Whaley K., Cone R. Antibody diffusion in human cervical mucus. Biophys. J. 66:(2 Pt 1):1994;508-515.
40. Gaigalas A., Hubbard J., LeSage R., Atha D. Physical characterization of heparin by light scattering. J. Pharm. Sci. 84:(3):1995;355-359.